Donald Wuchterl
Director/Board Member at ABEONA THERAPEUTICS INC.
Net worth: 239 815 $ as of 2024-04-29
Donald Wuchterl active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. | Director/Board Member | 2021-04-18 | - |
| Independent Dir/Board Member | 2021-04-18 | - | |
| T-Knife Therapeutics, Inc. | Corporate Officer/Principal | - | - |
Career history of Donald Wuchterl
Former positions of Donald Wuchterl
| Companies | Position | Start | End |
|---|---|---|---|
| AUDENTES THERAPEUTICS, INC. | Corporate Officer/Principal | 2015-12-31 | 2020-12-31 |
Cytovance Biologics, Inc.
 Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Chief Operating Officer | - | - |
Training of Donald Wuchterl
| Fitchburg State University | Masters Business Admin |
| Colorado Technical University, Inc. | Undergraduate Degree |
Statistics
International
| United States | 7 |
Operational
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ABEONA THERAPEUTICS INC. | Health Technology |
| Private companies | 3 |
|---|---|
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |
Cytovance Biologics, Inc.
Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Health Technology |
| T-Knife Therapeutics, Inc. |
- Stock Market
- Insiders
- Donald Wuchterl
- Experience